GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED financial statements, including revenue, expenses, profit, and loss

The total revenue of 600332 for the last quarter is 17.24 B CNY, and it's 4.98% lower compared to the previous quarter. The net income of Q4 23 is 264.43 M CNY.